Spero therapeutics inc.

Major-Pharmaceuticals

SPRO


675 Massachusetts Avenue
Cambridge , MA 02139

Executive/
Director

Price

  • Last Close
  • $ 1.1
    $ +0.03 2.8 %
    Jan 3, 2025
  • 52-Week High/Low
  • $1.81 - $1
  • YTD
  • 6.8%

  • Trading Volume
  • 5,577
  • Market Cap Full
  • $ 58.3M
  • Shares Outstanding
  • 53M
    Nov 6, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - 21.3% 108.3% -5% -24.1% -45.7% -16.2% 17% 6.8%
Q2 -69% -69% 3.3% -16% 4% -5.2% -91.5% - -26% -
Q3 -69% -69% -33.7% -7.7% 8% 31.9% 169.9% -16.6% -2.1% -
Q4 -69% 2.2% -42.6% -16% 73.8% -13% -13.5% 23.5% -9.7% -
J F M A M J J A S O N D
2025 6.8% - - - - - - - - - - -
2024 3.4% 8.6% 4.2% -18.6% 1.4% -5.6% 4.5% -2.1% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    130%0%0%-48%48%113%-17%-89%-15%-30%7%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -0.74 -0.29 -1.22 -0.66 -1.01 -0.25
Q2 - - -0.69 -0.74 -0.85 -0.63 -0.87 -0.23
Q3 - 36.02 -0.6 -0.95 -0.86 -0.7 -0.33 -0.06
Q4 - 1.59 -0.57 -1.37 -0.59 -0.92 0.98 -
A 0 37.6 -2.6 -3.4 -3.5 -2.9 -1.2 -0.54

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 17.2 20.3 29.5 32.8 52.6
Jun 14.4 17.5 20.6 29.7 32.8 52.6
Sep 18.2 18.7 21.2 32.1 35.1 52.7
Dec 18.2 19.1 27.2 32.3 51.8 53

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 9 2.6 1.3 3 1
Total Asset Turnover 0.4 0.1 0.1 0.2 -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -10.5 -44 79 31.5 43
Equity multiplier 0.1 0.1 0.1 0.1 -